Dow Up 1.63% Nasdaq Up 0.97%

Isis Pharmaceuticals, Inc. (ISIS)

-NMS
39.87 Oct 17, 4:00PM EDT
|Pre-Market : 40.55 Up 0.68 (1.71%) 8:52AM EDT - Nasdaq Real Time Price
Prev Close:39.87
Open:N/A
Bid:40.58 x 700
Ask:40.74 x 400
1y Target Est:47.30
Beta:1.69
Earnings Date:Nov 3 - Nov 13 (Est.)
Day's Range:N/A - N/A
52wk Range:22.25 - 62.66
Volume:400
Avg Vol (3m):1,995,230
Market Cap:4.69B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISIS 0.00%4.69B
ENZ215.84M
GILD152.30B
SRPT909.31M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.76
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback